Quality of Life with Advanced Metastatic Prostate Cancer

被引：24
|
作者：
Resnick, Matthew J. [1 ,2 ]
Penson, David F. [1 ,2 ]
机构：
[1] Vanderbilt Univ, Dept Urol Surg, Ctr Surg Qual & Outcomes Res, Nashville, TN 37232 USA
[2] VA Tennessee Valley Geriatr Res Educ & Clin Ctr G, Nashville, TN 37212 USA
来源：
UROLOGIC CLINICS OF NORTH AMERICA | 2012年 / 39卷 / 04期
关键词：
Prostate cancer; Metastatic; Castrate-resistant; Quality of life; Functional status; Palliation; ANDROGEN-DEPRIVATION THERAPY; PAINFUL BONE METASTASES; SICKNESS IMPACT PROFILE; MITOXANTRONE PLUS PREDNISONE; HEALTH-STATUS; PHASE-II; RADIONUCLIDE TREATMENT; ASYMPTOMATIC MEN; RANDOMIZED-TRIAL; ZOLEDRONIC ACID;
D O I：
10.1016/j.ucl.2012.07.007
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
The health-related quality-of-life (HRQOL) implications of advanced metastatic prostate cancer are variable. There are several different HRQOL instruments that measure domains germane to patients with advanced metastatic disease. The burden of prostate cancer is inversely related to the magnitude of HRQOL declines. Treatment with androgen deprivation therapy commonly results in HRQOL declines that have served as the impetus for intermittent therapy. Conversely, chemotherapeutic agents have been associated with improvements in functional status for men with castrate-resistant disease. Emerging therapies may result in significant HRQOL improvements in this population, and careful prospective evaluation of patient-reported outcomes will be required.
引用
收藏
页码：505 / +
页数：12
相关论文
共 50 条
  • [21] Supportive care, pain management, and quality of life in advanced prostate cancer
    Esper, P
    Redman, BG
    UROLOGIC CLINICS OF NORTH AMERICA, 1999, 26 (02) : 375 - +
  • [22] The role of mindfulness in distress and quality of life for men with advanced prostate cancer
    Chambers, Suzanne K.
    Foley, Elizabeth
    Clutton, Samantha
    McDowall, Robert
    Occhipinti, Stefano
    Berry, Martin
    Stockler, Martin R.
    Lepore, Stephen J.
    Frydenberg, Mark
    Gardiner, Robert A.
    Davis, Ian D.
    Smith, David P.
    QUALITY OF LIFE RESEARCH, 2016, 25 (12) : 3027 - 3035
  • [23] Health-related quality of life of metastatic prostate cancer patients treated with prostate Radiotherapy
    Ayoub, Heba Maged
    Zamzam, Maha Lotfy
    Elsemary, Eman Essam
    Hassanin, Ihab Mohamed
    Elsayed, Fifi Mostafa
    BMC CANCER, 2023, 23 (01)
  • [24] Health-related quality of life of metastatic prostate cancer patients treated with prostate Radiotherapy
    Heba Maged Ayoub
    Maha Lotfy Zamzam
    Eman Essam Elsemary
    Ihab Mohamed Hassanin
    Fifi Mostafa Elsayed
    BMC Cancer, 23 (1)
  • [25] Factors influencing quality of life and well being in metastatic prostate cancer patients
    Bouassida, K.
    Loghmari, A.
    Ben Othmen, M.
    Tlili, G.
    Acacha, E.
    Ben Abdallah, W.
    Kahloul, M.
    Hmida, W.
    Jaidane, M.
    EUROPEAN PSYCHIATRY, 2023, 66 : S943 - S944
  • [26] Goserelin (Zoladex®) or orchiectomy in metastatic prostate cancer?: Quality of life and cost.
    Norum, J
    Nygård, R
    Due, J
    ANNALS OF ONCOLOGY, 2000, 11 : 73 - 73
  • [27] Health-related quality of life among patients with metastatic prostate cancer
    Albertsen, PC
    Aaronson, NK
    Muller, MJ
    Keller, SD
    Ware, JE
    UROLOGY, 1997, 49 (02) : 207 - 216
  • [28] Considering quantity and quality of life in metastatic castration-naive prostate cancer
    Penson, David F.
    LANCET ONCOLOGY, 2018, 19 (02): : 153 - +
  • [29] Spirituality and quality of life in low-income men with metastatic prostate cancer
    Zavala, Mary Wassel
    Maliski, Sally L.
    Kwan, Loma
    Fink, Arlene
    Litwin, Mark S.
    PSYCHO-ONCOLOGY, 2009, 18 (07) : 753 - 761
  • [30] Changes in patients' quality of life following treatment of localized and metastatic prostate cancer
    Faydaci, Gokhan
    Metin, Mustafa
    Eryildirim, Bilal
    Tarhan, Fatih
    Tuncer, Murat
    Ozgul, Aydin
    TURKISH JOURNAL OF UROLOGY, 2011, 37 (03): : 184 - 190
12345